Shunli Shen

机构：Sun Yat-sen University, The First Affiliated Hospital, Sun Yat-sen University · ORCID：0000-0002-3133-3508

发表论文 73 篇 · 总被引 1053 次 · h-index 18

代表论文

• Anti-PD-1 antibody in combination with radiotherapy as first-line therapy for unresectable intrahepatic cholangiocarcinoma (2024 · BMC Medicine · 被引 25)
• Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition) (2024 · BioScience Trends · 被引 20)
• Adjuvant Transarterial Chemoembolization With Sorafenib for Portal Vein Tumor Thrombus (2024 · JAMA Surgery · 被引 15)
• Adjuvant Chemoradiation and Immunotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Cancer (2025 · JAMA Oncology · 被引 13)
• Surgical treatment improves overall survival of hepatocellular carcinoma with extrahepatic metastases after conversion therapy: a multicenter retrospective study (2024 · Scientific Reports · 被引 8)
• Conversion Therapy Based on TACE/HAIC-Based Treatment to Improve the Therapeutic Effect of Initially Unresectable Hepatocellular Carcinoma (2025 · Liver Cancer · 被引 6)